Antibody structure and function: the basis for engineering therapeutics
ML Chiu, DR Goulet, A Teplyakov, GL Gilliland - Antibodies, 2019 - mdpi.com
Antibodies and antibody-derived macromolecules have established themselves as the
mainstay in protein-based therapeutic molecules (biologics). Our knowledge of the structure …
mainstay in protein-based therapeutic molecules (biologics). Our knowledge of the structure …
[HTML][HTML] Advances and challenges in therapeutic monoclonal antibodies drug development
The use of serum containing polyclonal antibodies from animals immunized with toxins
marked the beginning of the application of antibody-based therapy in late nineteenth …
marked the beginning of the application of antibody-based therapy in late nineteenth …
A rational strategy for reducing on-target off-tumor effects of CD38-chimeric antigen receptors by affinity optimization
E Drent, M Themeli, R Poels, R de Jong-Korlaar… - Molecular therapy, 2017 - cell.com
Chimeric antigen receptors (CARs) can effectively redirect cytotoxic T cells toward highly
expressed surface antigens on tumor cells. The low expression of several tumor-associated …
expressed surface antigens on tumor cells. The low expression of several tumor-associated …
[HTML][HTML] Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma
Adoptive transfer of chimeric antigen receptor-transduced T cells is a promising strategy for
cancer immunotherapy. The CD38 molecule, with its high expression on multiple myeloma …
cancer immunotherapy. The CD38 molecule, with its high expression on multiple myeloma …
Engineered phage-based cancer vaccines: current advances and future directions
M Ragothaman, SY Yoo - Vaccines, 2023 - mdpi.com
Bacteriophages have emerged as versatile tools in the field of bioengineering, with
enormous potential in tissue engineering, vaccine development, and immunotherapy. The …
enormous potential in tissue engineering, vaccine development, and immunotherapy. The …
Simultaneous affinity maturation and developability enhancement using natural liability-free CDRs
Affinity maturation is often a necessary step for the development of potent therapeutic
molecules. Many different diversification strategies have been used for antibody affinity …
molecules. Many different diversification strategies have been used for antibody affinity …
Phage-displayed peptides for targeting tyrosine kinase membrane receptors in cancer therapy
Receptor tyrosine kinases (RTKs) regulate critical physiological processes, such as cell
growth, survival, motility, and metabolism. Abnormal activation of RTKs and relative …
growth, survival, motility, and metabolism. Abnormal activation of RTKs and relative …
Microcystin-LR heterologous genetically engineered antibody recombinant and its binding activity improvement and application in immunoassay
C Xu, D He, Y Zu, S Hong, J Hao, J Li - Journal of Hazardous Materials, 2021 - Elsevier
Abstract Microcystin-LR (MC-LR) is a high-toxic biohazard that pollutes ecological
environment and agroproducts. In this study, a newly recombined genetically engineered …
environment and agroproducts. In this study, a newly recombined genetically engineered …
High throughput functional epitope mapping: revisiting phage display platform to scan target antigen surface
G Rojas, Y Tundidor, YC Infante - MAbs, 2014 - Taylor & Francis
Antibody engineering must be accompanied by mapping strategies focused on identifying
the epitope recognized by each antibody to define its unique functional identity. High …
the epitope recognized by each antibody to define its unique functional identity. High …
Antibody Affinity and Stability Maturation by Error-Prone PCR
N Langreder, D Schäckermann, T Unkauf… - Phage Display: Methods …, 2023 - Springer
Human antibodies are the most important class of biologicals, and antibodies–human and
nonhuman–are indispensable as research agents and for diagnostic assays. When …
nonhuman–are indispensable as research agents and for diagnostic assays. When …